Free Submission Public Relations &
Deutsch English


Samedan app – now available!

Print article Print article

Samedan App Logo
Samedan App Logo
2013-12-06 16:15:10 - London, 5th December 2013, Samedan Ltd has launched a new app for iPhone and iPad, bringing together the digital editions of its six market-leading titles.

The Samedan app allows users to read the latest issues from its five specialist magazines – European Pharmaceutical Contractor, International Clinical Trials, European Biopharmaceutical Review, Pharmaceutical Manufacturing and Packing Sourcer and Innovations in Pharmaceutical Technology – as well as its monthly newspaper, Pharmafocus. Featuring in-depth news, expert articles and case studies, the app is an essential resource for pharma professionals worldwide.

The app also offers fully optimised, searchable content within each edition, including an extensive archive dating back to 2008. As well as being able to access the latest issues as soon as they are published, users can download the editions for offline reading and share articles with colleagues via social media.

The app is now available globally from the Apple

App Store here: and is free to download to your iPhone and iPad directly to Newsstand. For more information, go to

Samedan Ltd Pharmaceutical Publishers has been a leader in the pharmaceutical industry since 1996, and publishes a range of specialist titles for decision-makers across the pharma market, from R&D to drug delivery. In 2013, Samedan acquired Pharmafocus and, adding a monthly industry newspaper and comprehensive directory to its portfolio.

Contact Information:
Samedan Ltd

131 Edgware Road
W2 2HR

Contact Person:
Verity Bingham
Marketing Assistant
Phone: +44 (0) 207 724 3456
email: email


Verity Bingham
Phone: 02077243456

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact